18F-FDG PET/CT has prognostic value for cervical cancer recurrence

04/4/2010 | HealthImaging.com

A South Korean study involving cervical cancer patients found that the preoperative maximum standardized uptake value of 18F-FDG PET/CT in the primary tumor can be linked to cancer recurrence. The researchers also saw an increase in the median preoperative SUVmax values in the primary tumors of patients with higher FIGO stages and larger tumors, among other indications.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA